anmelden
BX Swiss TOP 30 CHF
1.443,63
PKT
-14,77
PKT
-1,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.09.26 | Givaudan Hold | Jefferies & Company Inc. | |
| 18.09.26 | Swiss Re Kaufen | DZ BANK | |
| 18.09.26 | Nestlé Buy | Jefferies & Company Inc. | |
| 18.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.09.26 | Novartis Hold | Deutsche Bank AG | |
| 18.09.26 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.26 | Richemont Buy | UBS AG | |
| 17.09.26 | Richemont Outperform | Bernstein Research | |
| 17.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 17.09.26 | Novartis Neutral | UBS AG | |
| 16.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 15.09.26 | Novartis Hold | Deutsche Bank AG | |
| 14.09.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 14.09.26 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 11.09.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.26 | Richemont Outperform | RBC Capital Markets | |
| 09.09.26 | Novartis Hold | Deutsche Bank AG | |
| 09.09.26 | Novartis Sector Perform | RBC Capital Markets | |
| 08.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Novartis Sell | Deutsche Bank AG | |
| 08.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 08.09.26 | Novartis Equal Weight | Barclays Capital | |
| 08.09.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | Nestlé Market-Perform | Bernstein Research | |
| 07.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.09.26 | Swiss Re Underperform | RBC Capital Markets | |
| 04.09.26 | Swiss Re Underweight | Barclays Capital | |
| 04.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 03.09.26 | Givaudan Buy | Deutsche Bank AG | |
| 02.09.26 | Novartis Buy | Deutsche Bank AG | |
| 02.09.26 | Nestlé Neutral | UBS AG | |
| 02.09.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 01.09.26 | Novartis Neutral | UBS AG | |
| 01.09.26 | Novartis Hold | Jefferies & Company Inc. | |
| 01.09.26 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Givaudan Hold | Jefferies & Company Inc. | |
| 01.09.26 | UBS Outperform | RBC Capital Markets | |
| 31.08.26 | UBS Buy | Jefferies & Company Inc. | |
| 28.08.26 | Novartis Buy | Deutsche Bank AG | |
| 28.08.26 | Givaudan Underperform | Bernstein Research |
